Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
11/2009
11/19/2009WO2009140642A2 Tricyclic antagonists of prostaglandin d2 receptors
11/19/2009WO2009140566A1 Method for producing bicyclic guanidines by use of a cyclic thiourea
11/19/2009WO2009140500A1 Hepatitis c virus inhibitors
11/19/2009WO2009140128A2 Compounds and compositions as kinase inhibitors
11/19/2009WO2009139947A2 Permselective membrane-free direct fuel cell and components thereof
11/19/2009WO2009139916A1 Tricyclic triazole compounds that modulate hsp90 activity
11/19/2009WO2009139362A1 Pharmaceutical preparation comprising dpp-iv inhibitor and other diabetes therapeutic agent in concomitant or combined form
11/19/2009WO2009139076A1 Lipoprotein lipase-activating compositions comprising benzene derivates
11/19/2009WO2009138796A2 Substituted quinazolines
11/19/2009WO2009138795A1 Substituted quinazolines
11/19/2009WO2009138794A1 Imidazoquinazoline derivatives as anagrelide analogues for the treatment of myeloprolific diseases and thrombotic diseases
11/19/2009WO2009138793A1 Substituted quinazolines as blood platelet lowering agents
11/19/2009WO2009138791A1 2h- pyrimido [2, 1-b] quinaz0lin-2-0ne derivatives and their use as platelet anti-aggregative agents
11/19/2009WO2009138790A1 Substituted quinazolines and their uses for myeoloprolific and thrombotic diseases
11/19/2009WO2009138789A1 Substituted quinazolines as blood platelet lowering agents
11/19/2009WO2009138440A1 Carbamoyl derivatives of bicyclic carbonylamino-pyrazoles as prodrugs
11/19/2009WO2009138176A1 Substituted imidazo- and triazolopyrimidines, imidazo- and pyrazolopyrazines and imidazotriazines as gsk3beta-inhibitors
11/19/2009WO2008145839A8 Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof
11/19/2009US20090286993 Process for producing cyclic n-hydroxy imide compounds
11/19/2009US20090286990 Process for preparing irbesartan
11/19/2009US20090286945 e.g. dimethylsilanediyl(cyclopentadienyl)(7-cyclopentadipyrrole)zirconium dichloride; triethylaluminum or alumoxane cocatalyst; homo or copolymerizing ethyelene and propylene; molecular weight control
11/19/2009US20090286841 Certain chemical entities, compositions, and methods
11/19/2009US20090286827 Novel bi-aryl amines
11/19/2009US20090286825 {7-[[(4-fluorophenyl)sulfonyl](methyl)amino]-6,7,8,9-tetrahydropyrido[1,2-a]indol-10-yl}acetic acid; prostaglandine D2 receptor antagonists ; respiratory, inflammatory or allergic conditions; chemoattractant receptor-homologous molecule expressed on TH2 cells (CRTH2)
11/19/2009US20090286812 GPR119 Receptor Agonists
11/19/2009US20090286798 Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases
11/19/2009US20090286796 Compounds exhibiting type X sPLA2 inhibiting effect
11/19/2009US20090286783 Pyrrolo(2,3-d)pyrimidine kinase inhibitors; melanoma, colorectal cancer, pain, polycystic kidney disease and other Raf protein kinase related conditions; e.g. Propane-1-sulfonic acid[3-(4-cyclopropyl-7H-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-2,4-difluoro-phenyl]-amide; Raf kinases including B-raf, A-raf
11/19/2009US20090286782 Compounds and methods for kinase modulation, and indications therefor
11/19/2009US20090286781 Use of Suluble Guanylate Cyclase Acitvators for Treating Acute and Chronic Lung Diseases
11/19/2009US20090286779 Pyrazolopyrimidines as lipid kinase inhibitors
11/19/2009US20090286778 Macrocyclic compounds and their use as kinase inhibitors
11/19/2009US20090286774 Purinone derivatives as hm74a agonists
11/19/2009US20090286771 2-Phenoxy- and 2-Phenylsulfonamide Derivatives with CCR3 Antagonistic Activity for the Treatment of Inflammatory or Immunological Disorders
11/19/2009US20090286768 Substituted imidazopyr- and imidazotri-azines
11/19/2009US20090286766 Azolecarboxamide derivative
11/19/2009US20090285849 Thiosemicarbazones as anti-virals and immunopotentiators
11/19/2009US20090285783 Methods and compositions for cancer therapy using a novel adenovirus
11/19/2009US20090285773 Hepatitis C Virus Inhibitors
11/19/2009CA2724216A1 2h- pyrimido [2, 1-b] quinazolin-2-one derivatives and their use as platelet anti-aggregative agents
11/19/2009CA2724215A1 Carbamoyl derivatives of bicyclic carbonylamino-pyrazoles as prodrugs
11/19/2009CA2724213A1 Substituted quinazolines as blood platelet lowering agents
11/19/2009CA2724181A1 Imidazoquinazoline derivatives as anagrelide analogues for the treatment of myeloprolific diseases and thrombotic diseases
11/19/2009CA2724180A1 Substituted quinazolines
11/19/2009CA2724133A1 Medicine consisting of concomitant use or combination of dpp-iv inhibitor and other diabetic medicine
11/19/2009CA2724066A1 Method for producing bicyclic guanidines by use of a cyclic thiourea
11/19/2009CA2724035A1 Substituted quinazolines
11/19/2009CA2724020A1 Substituted quinazolines and their uses for myeoloprolific and thrombotic diseases
11/19/2009CA2723958A1 Substituted quinazolines
11/19/2009CA2723858A1 Substituted quinazolines
11/19/2009CA2723455A1 Lipoprotein lipase-activating compositions comprising benzene derivates
11/19/2009CA2722418A1 Fused nitrogen containing heterocycles and compositions thereof as kinase inhibitors
11/19/2009CA2722056A1 Hcv protease inhibitors
11/18/2009EP2118113A1 Pyridyl-triazolopyrimidine derivative or its salt, pesticide containing it and its production process
11/18/2009EP2118110A1 Cyclopropyl fused indolobenzazepine hcv inhibitors
11/18/2009EP2118109A1 Compounds for the treatment of hepatitis c
11/18/2009EP2118108A1 Compounds for the treatment of hepatitis c
11/18/2009EP2118067A1 Nicotinic acetylcholine receptor modulators
11/18/2009EP2117526A2 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
11/18/2009EP2117311A1 Therapeutic agents
11/18/2009EP0892789B2 Irreversible inhibitors of tyrosine kinases
11/18/2009EP0764168B1 Heteroatom-functionalized porphyrazines and multimetallic complexes and polymers derived therefrom
11/18/2009CN101583614A Polycyclic agents for the treatment of respiratory syncytial virus infections
11/18/2009CN101583613A Method for production of aryl-substituted annelated pyrimidines
11/18/2009CN101583611A Inhibitors of hepatitis C virus
11/18/2009CN101583365A Triazine derivatives and their therapeutical applications
11/18/2009CN101580535A Hcv protease inhibitors
11/18/2009CN101580523A Novel chemical substance having activity for morphogenesis and growth promotion
11/18/2009CN101580506A 1-3 generation arylene ether dendritic phthalocyanine complex and polymer nano-particle thereof
11/18/2009CN101580505A Derivatives of pyrrolo[2,1-b]quinazoline natural products, preparation method and application thereof
11/18/2009CN100560585C New benzimidazole derivative
11/18/2009CN100560548C Synthesis process of 18F labeled positive electron radioactive tracer with ionic liquid as phase transfer catalyst
11/17/2009US7619100 Physiologically active substances
11/17/2009US7619089 Formulations and use of e.g. 2-chloro-N-(8 alpha ,9S)cinchonan-9-yl)-3-trifluoromethyl-benzamide hydrochloride for treating pain, Parkinson's disease, epilepsy, sleep apnea, alcoholism, psychological disorders, migraines
11/17/2009US7619083 Intermediates useful in preparing certain pyrrolotriazine compounds and process for making such intermediates
11/17/2009US7618983 Bicyclic triazole α4 integrin inhibitors
11/17/2009US7618981 Imidazopyridinyl-benzamide anti-cancer agents
11/17/2009US7618976 Methods for the production of sildenafil base and citrate salt
11/17/2009US7618975 4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis; antiproliferative, anticarcinogenic, antimetabolic agents; tubulin and topoisomerase II inhibitors; fungicides; synergistic administration with other anticarcinogenic agents
11/17/2009US7618963 Bicyclic heteroaromatic compounds
11/17/2009US7618958 Stereospecific anxiolytic and anticonvulsant agents with reduced muscle-relaxant, sedative-hypnotic and ataxic effects
11/17/2009US7618621 Preparing culture of pluripotent brain tissue for nervous tissue regeneration, tissue engineering and treating nervous system disorders
11/17/2009CA2407094C Diazabicyclic central nervous system active agents
11/17/2009CA2393809C Heterocyclic dihydropyrimidines as potassium channel inhibitors
11/17/2009CA2314188C Rigidized trimethine cyanine dyes
11/17/2009CA2259583C Azolo triazines and pyrimidines
11/12/2009WO2009137728A2 Method for producing bicyclic guanidines by use of a cyclic urea
11/12/2009WO2009137596A1 Substituted amides, method of making, and use as btk inhibitors
11/12/2009WO2009137454A1 7h-indolo[2,1-a] [2] benzazepine-10-carboxylic acid derivatives for the treatment of hepatitis c
11/12/2009WO2009137308A1 Selective ligands for the neuronal nicotinic receptors and uses thereof
11/12/2009WO2009137291A2 Spiroazaindoles
11/12/2009WO2009137130A2 Antibacterial fluoroquinolone analogs
11/12/2009WO2009136966A1 Inhibitors of protein kinases
11/12/2009WO2009136596A1 Organic electroluminescent element
11/12/2009WO2009136595A1 Compound for organic electric field light-emitting element and organic electric field light-emitting element
11/12/2009WO2009136191A1 Chemical compounds
11/12/2009WO2009135842A1 Azetidines and cyclobutanes as histamine h3 receptor antagonists
11/12/2009WO2009135599A1 1,4-diaryl-pyrimidopyridazine-2,5-diones and their use
11/12/2009WO2009095282A3 Photolatent amidine bases for redox curing of radically curable formulations
11/12/2009WO2009083532A3 Novel method for the preparation of derivatives of dihydrotetraazapentacenes, products such as obtained, and uses thereof
1 ... 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 ... 573